Real world evidence for legacy effect of early glycaemic control in type 2 diabetes on risk of macrovascular disease
| Huvudupphovsmän: | , , , , , |
|---|---|
| Materialtyp: | Conference item |
| Språk: | English |
| Publicerad: |
Springer
2017
|
| Sammanfattning: |
|---|